CN114010689A

CN114010689A - Medicine for treating respiratory tract disease and its preparing method

Info

Publication number: CN114010689A
Application number: CN202111601749.8A
Authority: CN
Inventors: 杨棕嵌
Original assignee: Individual
Current assignee: Individual
Priority date: 2021-12-24
Filing date: 2021-12-24
Publication date: 2022-02-08

Abstract

The invention provides a medicament for treating respiratory diseases and a preparation method thereof, and relates to the technical field of medicinal preparations. The medicine comprises the following components: astragalus root, pneumocardial, honeysuckle flower, ginseng, almond and fruit stone. The preparation method comprises the following steps: mixing radix astragali, cor pulmonale, flos Lonicerae, Ginseng radix, semen Armeniacae amarum and semen Persicae to obtain mixture, adding water into the mixture, vacuum distilling, and filtering to obtain medicinal liquid. The medicine of the present invention has the function of killing various pneumonia and pulmonary tuberculosis viruses, has good treatment effect on respiratory system diseases, digestive system diseases and blood system diseases, and has the advantages of difficult recurrence and no toxic or side effect. The preparation method of the invention adopts a distillation process, can improve the concentration of effective components, enables the medicine to better exert the drug effect and improves the treatment effect on diseases.

Description

Medicine for treating respiratory tract disease and its preparing method

Technical Field

The invention relates to the technical field of medicinal preparations, in particular to a medicament for treating respiratory diseases and a preparation method thereof.

Background

Respiratory tract infection is the general term for acute inflammation of nasal cavity, pharynx or larynx, and has strong infectivity, high incidence rate, and can be complicated with various diseases (such as pneumonia, myocarditis, nephritis and rheumatic diseases). The disease is mainly transmitted through droplets and droplets containing viruses or polluted appliances, and when the resistance of the organism is reduced, such as the conditions of catching cold, tiredness, rain and the like, viruses and bacteria with pathogens existing or entering from the outside at night grow and propagate rapidly to cause infection.

At present, respiratory diseases are treated by antibiotics, but the antibiotics easily cause dysbacteriosis and bacterial drug resistance and are easy to relapse.

Disclosure of Invention

The invention aims to provide a medicament for treating respiratory diseases, which has a killing effect on various pneumonia and phthisis viruses, has a good treatment effect on respiratory diseases, digestive system diseases and blood system diseases, is not easy to relapse, and has no toxic or side effect.

The invention also aims to provide a preparation method of the medicine for treating the respiratory diseases, which adopts a distillation process to treat raw materials, can improve the concentration of effective components, enables the medicine to better exert the medicine effect and improves the treatment effect on the diseases.

The technical problem to be solved by the invention is realized by adopting the following technical scheme.

The invention provides a medicament for treating respiratory diseases, which comprises the following raw materials in parts by mass: 5-15% of astragalus membranaceus, 6-18% of pneumocardial, 10-20% of honeysuckle, 5-12% of ginseng, 3-14% of apricot kernel and 40-60% of fruit stone.

The invention provides a preparation method of a medicament for treating respiratory diseases, which comprises the following steps:

mixing radix astragali, cor pulmonale, flos Lonicerae, Ginseng radix, semen Armeniacae amarum and semen Persicae to obtain mixture, adding water into the mixture, vacuum distilling, and filtering to obtain medicinal liquid.

The embodiment of the invention at least has the following beneficial effects:

in the invention, the astragalus root prevents repeated attack of diseases through the regulation effect on Th1/Th2 cell factors of an organism; the onset of RRI is reduced and the course of disease is shortened by a series of regulation effects of increasing the levels of immunoglobulin IgG1 and IgG3, enhancing humoral immunity, inducing interferon generation, enhancing macrophage phagocytosis and the like; can be used for treating respiratory diseases by inhibiting or blocking cytopathic process, enhancing natural killer cell activity and antivirus effect. The pulmonanthus praecox has the effects of relieving cough and asthma by relieving lung heat and dryness of the lung of the body; by inhibiting the activity of various bacteria and viruses in human body, the morbidity is reduced. Flos Lonicerae has anti-inflammatory effect by inhibiting inflammatory exudation and inflammatory hyperplasia. Ginseng radix has effects of improving immunity by invigorating primordial qi. The almond has the effects of relieving cough and asthma by inhibiting the respiratory center. The fruit stones improve respiratory diseases and lung functions through maintenance. The combination of the medicines can treat and improve respiratory diseases from multiple aspects, has the effect of mutual promotion, and enables the medicines to better treat respiratory diseases and avoid repeated attack thereof. The raw materials are reasonable in proportion and supplement each other, and the traditional Chinese medicine composition has the effects of clearing heat and moistening lung, nourishing stomach and tonifying spleen, and further enhancing the drug effect. In addition, the medicine of the invention also has the functions of relaxing bowel and regulating blood, so that the medicine also has certain treatment effect on digestive system diseases and blood system diseases.

In the invention, the distillation process is adopted to treat the raw materials, so that the active ingredients of the raw materials can be better extracted, the content of the active ingredients can be increased, and the concentration of the active ingredients in the liquid medicine is higher, thereby the medicine can better exert the medicine effect and enhancing the treatment effect of the medicine on respiratory diseases.

Detailed Description

In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.

It should be noted that the embodiments and features of the embodiments in the present application may be combined with each other without conflict. The present invention will be described in detail below with reference to specific examples.

The medicine for treating the respiratory diseases comprises the following raw materials in parts by mass: 5-15% of astragalus membranaceus, 6-18% of pneumocardial, 10-20% of honeysuckle, 5-12% of ginseng, 3-14% of apricot kernel and 40-60% of fruit stone.

Astragalus root, sweet in flavor, slightly warm in nature; it has effects in invigorating qi, consolidating exterior, expelling toxin, expelling pus, promoting urination, and promoting granulation. Can be used for treating deficiency of vital energy, asthenia, chronic diarrhea, proctoptosis, spontaneous perspiration, edema, uterine prolapse, albuminuria due to chronic nephritis, diabetes, and unhealed wound. The astragaloside has antibacterial and antiviral effects, can inhibit or block cytopathic process, and has effects of regulating humoral immunity and cellular immunity, and enhancing natural killer cell activity and antiviral effect. Radix astragali has effects of reducing recurrent attacks of respiratory diseases, increasing organism Th1 cytokine, and reducing Th2 cytokine. The mechanism is as follows: astragalus root promotes the expression of IL-2mRNA in lymphocytes, reduces the inhibition of Ts cells on lymphocyte I-2mRNA, and is related to the clear induction of IFN-7. Radix astragali has obvious regulating effect on imbalance state of organism Th1/Th2 cytokine, and can prevent recurrent attack. In addition, astragalus can reduce the onset of RRI and shorten the course of disease by increasing the level of immunoglobulin IgG1 and IgG3, enhancing humoral immunity, inducing interferon production, enhancing macrophage phagocytosis and other immune regulation effects.

The pulmonary heart disease has effects of clearing heat, moistening lung, relieving swelling and pain, and can be used for treating pulmonary tuberculosis, parotitis, lymphadenitis, laryngitis, leucorrhea, toxic heat, sore, swelling, and traumatic injury. The product mainly contains saponin, anthraquinone, flavonoid aspidistrependrin, isomangiferin, etc. The pneumocardial herb can relieve the lung heat and the lung dryness of the organism, and has particularly obvious treatment effect on asthma, cough, excessive phlegm and other symptoms caused by the lung heat and the lung dryness; it also contains various natural medicinal components, and has effects of inhibiting activity of various bacteria and viruses in human body, reducing incidence of pneumonia, pulmonary tuberculosis and lymphoid tuberculosis, and inhibiting and eliminating influenza virus. The pneumocandin contains a large amount of pectin and cellulose, can clear heat toxin in intestinal tracts and relieve constipation caused by intestinal dryness, and the cellulose and the pectin can promote intestinal tract peristalsis after entering the intestinal tracts, thereby being beneficial to relaxing bowel and clearing the intestines to expel toxin.

Honeysuckle flower, cold in nature and sweet in taste, enters lung, heart and stomach meridians and has the effects of clearing away heat and toxic materials and cooling and dispelling wind-heat. The honeysuckle contains inositol, flavonoid, saponin, tannin and the like, has stronger inhibition effect on various pathogenic bacteria such as pneumonia bacillus, tuberculosis bacillus, typhoid bacillus, staphylococcus aureus, dysentery bacillus and the like, and also has inhibition effect on influenza virus. The honeysuckle can inhibit exudation of inflammation and inflammatory hyperplasia, and has anti-inflammatory effect; can also improve the phagocytic capacity of abdominal inflammatory cells and peripheral blood cells of the mice, and increase the activity of lysozyme in serum of the mice, thereby enhancing the immunity.

Ginseng, sweet in taste, slightly bitter in taste, warm in nature and neutral in nature, enters spleen, lung channel and heart channel, and has the effects of tonifying qi, relieving depletion, promoting fluid production, soothing nerves and promoting intelligence. Ginseng radix has adaptogen-like effect, and can enhance organism response ability to various harmful stimuli, protect stress response caused by various stimuli, recover disorder function, and enhance organism adaptability. Ginseng radix has effects of dilating blood vessel and regulating blood circulation.

The almond contains rich flavonoid and polyphenol components, fat, protein, vitamins, saccharides, inorganic salts and trace elements required by a human body, and has high nutritional value and excellent food therapy health-care effect; has the main functions of depressing qi, relieving cough and asthma, and relaxing bowel; can be used for treating cough, asthma, chest fullness, excessive phlegm, blood deficiency, dry body fluid, intestinal dryness, and constipation. The almond contains amygdalin and amygdalin, wherein the amygdalin can be hydrolyzed by the amygdalin, and the generated hydrocyanic acid and benzoic acid have the inhibition effect on the respiratory center, can deepen the breath and play the roles of relieving cough and asthma. In addition, amygdalin has anti-inflammatory and analgesic effects.

The fruit stones contain rich vitamins, amino acids, mineral substances and the like, so that the respiratory diseases and the lung function can be improved, the effects of maintaining respiratory tracts, lungs and livers can be achieved, the medicine is good in curative effect, and relapse is not easy to occur.

The astragalus root prevents repeated attack of diseases through the regulation effect on Th1/Th2 cell factors of an organism; the onset of RRI is reduced and the course of disease is shortened by a series of regulation effects of increasing the levels of immunoglobulin IgG1 and IgG3, enhancing humoral immunity, inducing interferon generation, enhancing macrophage phagocytosis and the like; can be used for treating respiratory diseases by inhibiting or blocking cytopathic process, enhancing natural killer cell activity and antivirus effect. The pulmonanthus praecox has the effects of relieving cough and asthma by relieving lung heat and dryness of the lung of the body; by inhibiting the activity of various bacteria and viruses in human body, the morbidity is reduced. Flos Lonicerae has anti-inflammatory effect by inhibiting inflammatory exudation and inflammatory hyperplasia. Ginseng radix has effects of improving immunity by invigorating primordial qi. The almond has the effects of relieving cough and asthma by inhibiting the respiratory center. The fruit stones improve respiratory diseases and lung functions through maintenance. The combination of the medicines can treat and improve respiratory diseases from multiple aspects, has the effect of mutual promotion, and enables the medicines to better treat respiratory diseases and avoid repeated attack thereof. The raw materials are reasonable in proportion and supplement each other, and the traditional Chinese medicine composition has the effects of clearing heat and moistening lung, nourishing stomach and tonifying spleen, and further enhancing the drug effect. In addition, the medicine of the invention also has the functions of relaxing bowel and regulating blood, so that the medicine also has certain treatment effect on digestive system diseases and blood system diseases.

In this embodiment, the stone includes raw tea fruit, melon and fruit, and branchlet fruit. The raw tea fruit includes Camellia oleifera fruit, white tea fruit, Camellia japonica fruit and Ampelopsis grossedentata fruit. The melon and fruit includes pear, cherry, sugarcane, lemon, loquat, apple and orange.

The raw tea fruit contains tea polyphenols, tea saponin, vitamins and minerals. Wherein, the tea polyphenol has strong anti-aging effect and good curative effect on chronic pharyngitis and cardiovascular system diseases. The vitamins can promote metabolism and promote blood circulation of capillary vessel. The tea saponin has antiinflammatory and analgesic effects. The minerals are essential components of human body, and are helpful for enhancing immunity. The camellia oleifera fruit, the white tea fruit, the camellia fruit and the ampelopsis grossedentata fruit are used in a matching way, and have a synergistic effect.

The pear has the effects of promoting the production of body fluid to quench thirst, clearing heat and relieving cough, and can improve the functions of a respiratory system and a lung; it is nutritious, and has effects of nourishing yin and moistening lung. The cherry has the effects of moistening lung, promoting urination, clearing heat and invigorating spleen, has good liver nourishing effect, is rich in vitamin C, and can enhance body resistance. The sugarcane contains rich dietary fiber, can provide heat and nutrition for organisms, and has the effects of relieving swelling and pain. The lemon is rich in vitamin C, citric acid, malic acid, sodium, potassium, etc., has effects of clearing away heat and toxic materials, preventing common cold, stimulating appetite, resolving food stagnation, promoting fluid production, and quenching thirst. Loquat has the effect of moistening lung to arrest cough. The apple is nutritious, and has effects of moistening lung, relieving cough, and eliminating phlegm. Orange contains abundant vitamin C, and can supplement vitamins to resist inflammatory diseases.

The fructus Liquidambaris has effects of dispelling pathogenic wind, removing dampness, promoting blood circulation and relieving pain, and can be used for treating cough due to wind-heat. Moreover, the yacon contains rich protein, fat, reducing sugar, various vitamins, amino acids and the like, has high nutritive value and has the functions of promoting the production of body fluid to quench thirst and refreshing. The raw tea fruits, the melons and the fruits are matched for use, so that the nutritional ingredients are more sufficient, respiratory diseases caused by weakness and malnutrition are effectively improved, and the prevention or treatment effect is achieved.

It should be noted that the raw tea fruits and melons and fruits can also be other fruits with the functions of nutrition or the function of relieving respiratory diseases.

A preparation method of a medicine for treating respiratory diseases comprises the following steps:

mixing radix astragali, cor pulmonale, flos Lonicerae, Ginseng radix, semen Armeniacae amarum and semen Persicae to obtain mixture, pulverizing the mixture to 200 mesh fine powder with particle size of 150-.

The raw materials are mixed and then crushed, so that the particle size of the raw materials is reduced, the effective components in the raw materials are more convenient to extract, and when the particle size is 150-200 meshes, the extraction effect is the best. Meanwhile, the cell tissue of the fruit stone can be effectively damaged, so that the effective components in the fruit stone can be better extracted. Then soaking in 80-90 wt% ethanol for 20-30 min. The effective components in the raw materials can be dissolved in ethanol, the ethanol is selected for infiltration, part of the effective components in the raw materials can be dissolved out firstly, the distillation speed can be increased during the subsequent vacuum distillation, the effective components in the raw materials can be extracted more fully, and the content of the effective components is improved. Under the above conditions, the extraction rate and extraction efficiency of effective components are highest.

Vacuum distilling at 100-120 deg.C for 40-50 min. The vitamins, amino acids and the like in the fruit cores can be extracted by vacuum distillation, and the vacuum distillation under the above conditions does not damage the structures of the vitamins or the amino acids, can also ensure the extraction efficiency, and can ensure that the obtained vitamins and the amino acids have more complete structures and more content. Centrifuging at 800-. The particle in the liquid can be removed through centrifugation, the purity of the liquid is improved, and the liquid medicine is more convenient to use. Especially, during the atomization treatment, the secondary damage of the particles in the liquid medicine to the respiratory tract is avoided, and the tolerance of a user during the treatment is improved. Under the centrifugal rotation speed and the centrifugal rotation time, the particles in the liquid can be removed as fully as possible, and the quality of the obtained liquid medicine is optimal.

Optionally, the residue after vacuum distillation may be subjected to reflux extraction to obtain a reflux extract, and then the reflux extract and the filtered liquid are combined, centrifuged, and sterilized to obtain a liquid medicine. Therefore, the residual components in the filter residue can be further extracted, the content of the effective components is increased, the drug effect of the drug is better, and the treatment effect is better.

Optionally, the method further comprises concentrating the medicinal liquid, drying, and making into capsule. Compared with liquid medicine, the capsule is more convenient to carry and store, the medicine is not easy to deteriorate, and the use is more convenient.

The use method of the medicine prepared by the invention comprises the following steps: the liquid medicine can be directly taken orally, or the liquid medicine can be atomized by an atomization device (namely respiratory therapy), or a capsule can be selected for oral administration.

The features and properties of the present invention are described in further detail below with reference to examples.

Example 1

The medicine for treating the respiratory diseases comprises the following raw materials in parts by mass: 5% of astragalus mongholicus, 6% of pneumocardial, 10% of honeysuckle, 5% of ginseng, 14% of almond and 60% of fruit stones, and the raw materials are 1 kg.

mixing radix astragali, cor pulmonale, flos Lonicerae, Ginseng radix, semen Armeniacae amarum and semen Persicae to obtain mixture, adding water into the mixture, vacuum distilling at 100 deg.C for 40min, and filtering to obtain medicinal liquid.

Example 2

The medicine for treating the respiratory diseases comprises the following raw materials in parts by mass: 15% of astragalus mongholicus, 15% of pneumocardial, 15% of honeysuckle, 10% of ginseng, 5% of almond and 40% of fruit stones, and the raw materials are 1 kg.

mixing radix astragali, cor pulmonale, flos Lonicerae, Ginseng radix, semen Armeniacae amarum and semen Persicae to obtain mixture, adding water into the mixture, vacuum distilling at 120 deg.C for 50min, and filtering to obtain medicinal liquid.

Example 3

The medicine for treating the respiratory diseases comprises the following raw materials in parts by mass: 8 percent of astragalus root, 10 percent of pneumocardial grass, 12 percent of honeysuckle, 12 percent of ginseng, 8 percent of almond and 50 percent of fruit stone, and the raw materials are 1 kg.

mixing radix astragali, cor pulmonale, flos Lonicerae, Ginseng radix, semen Armeniacae amarum and semen Persicae to obtain mixture, adding water into the mixture, vacuum distilling at 110 deg.C for 45min, and filtering to obtain medicinal liquid.

Example 4

The medicine for treating the respiratory diseases comprises the following raw materials in parts by mass: 6% of astragalus mongholicus, 14% of pneumocardial, 18% of honeysuckle, 6% of ginseng, 11% of almond and 45% of fruit stones, and the raw materials are 1 kg.

mixing radix astragali, cor pulmonale, flos Lonicerae, Ginseng radix, semen Armeniacae amarum and semen Persicae to obtain mixture, soaking the mixture in 80 wt% ethanol for 20min, adding water, vacuum distilling at 110 deg.C for 45min, and filtering to obtain medicinal liquid.

Example 5

mixing radix astragali, cor pulmonale, flos Lonicerae, Ginseng radix, semen Armeniacae amarum and semen Persicae to obtain mixture, pulverizing the mixture to 150 mesh fine powder, adding water into the fine powder, vacuum distilling at 110 deg.C for 45min, and filtering to obtain medicinal liquid.

Example 6

mixing radix astragali, cor pulmonale, flos Lonicerae, Ginseng radix, semen Armeniacae amarum and semen Persicae to obtain mixture, pulverizing the mixture into fine powder with particle size of 200 mesh, soaking the fine powder in 90 wt% ethanol for 30min, adding water, vacuum distilling at 110 deg.C for 45min, filtering, and centrifuging at 900r/min for 8min to obtain medicinal liquid.

Example 7

The raw materials in this example are the same as in example 6, except that: mixing radix astragali, cor pulmonale, flos Lonicerae, Ginseng radix, semen Armeniacae amarum and semen Persicae to obtain mixture, pulverizing the mixture into fine powder with particle size of 200 mesh, soaking the fine powder in 90 wt% ethanol for 30min, adding water, vacuum distilling at 110 deg.C for 45min, filtering, centrifuging at 900r/min for 8min to obtain medicinal liquid, concentrating, drying, and making into capsule.

Results of the experiment

1. Animal drug effect test

1.1 antitussive test

80 mice, half of the males and females, were randomly divided into 8 groups, 7 groups for drug administration and a blank group. 7 groups of administration groups used the drugs of examples 1-7 of the invention in sequence, and administered by intragastric administration, 12.5g/kg, 1 time per day for 4 consecutive days; the blank group was gavaged with the same dose of physiological saline. After 1 hour of the last administration, an ammonia-induced cough test was performed, the mice were placed in a constant-pressure ammonia water spray device at a pressure of 140mmHg and an ammonia concentration of 28%, and were immediately taken out after receiving constant-pressure ammonia water spray for 15 seconds, and the cough latency and the number of times of cough of the mice within 2min were observed and recorded for each mouse, and the following data were the average values of each group, and the results are shown in table 1.

TABLE 1 results of the mouse antitussive test

As can be seen from Table 1, 1-7 groups had the effect of extending the incubation period and reducing the number of coughs in mice with ammonia-induced coughs, compared with the blank group. The 6 groups and 7 groups are different in dosage form, and have similar cough relieving effect. The 6 groups had the best antitussive effect compared to the 1-5 groups. Therefore, the medicine has obvious cough relieving effect and is helpful for treating respiratory diseases.

1.2 phlegm eliminating test

80 mice, half of the males and females, were randomly divided into 8 groups, 7 groups for drug administration and a blank group. 7 groups of administration groups used the drugs of examples 1-7 of the invention in sequence, and administered by intragastric administration, 12.5g/kg, 1 time per day for 5 consecutive days; the blank group was gavaged with the same dose of physiological saline. After 0.5h of the last administration, 0.1mL (mass fraction 0.5mg/g) of phenol red solution was injected into the vein, each mouse was sacrificed after 0.5h, the trachea was stripped off, a section of trachea from the inferior trachea of the thyroid cartilage was cut off, the trachea was placed in a 2mL test tube containing 0.9% physiological saline, 0.1mL of 0.1mol/L sodium hydroxide solution was added, OD was measured at a wavelength of 546nm to prepare a phenol red standard curve, and the phenol red content (. mu.g/mL) was calculated from the standard curve, and the following data were averaged for each group, and the results are shown in Table 2.

TABLE 2 phlegm eliminating test results

As is clear from Table 2, the amounts of phenol red discharged from the respiratory mucosa were increased in the groups 1 to 7 as compared with the blank group. Therefore, the medicaments of examples 1 to 7 of the invention have obvious phlegm eliminating effect.

2. Clinical trial

The preparation method comprises selecting 60 cases of chronic bronchitis, cough, pharyngitis and pneumonia, administering the medicine of example 6, respiratory therapy and oral liquid therapy to the cases, and administering the medicine of example 7, wherein 20 cases are selected for each therapy, 15mg is administered each time, 2 times a day, and 1 week is continuously administered. The case status was investigated after 1 week, and the specific results are shown in Table 3.

The treatment effect is judged according to the following standards:

and (3) healing: complete disappearance of symptoms or elimination of signs; the effect is shown: the symptoms or physical signs are obviously relieved or relieved by more than 75 percent; the method has the following advantages: symptoms or signs improved, but to a degree of less than 50%; and (4) invalidation: no improvement or aggravation after use.

TABLE 3 results of clinical trials

As can be seen from Table 3, the respiratory therapy has an obvious curative effect on chronic bronchitis, cough and pharyngitis; for pneumonia, the direct oral administration has better treatment effect. Wherein, the oral liquid has better treatment effect on respiratory diseases, and the oral capsule has better treatment effect on lung diseases. Therefore, when the medicament is used for treating respiratory diseases, the effect achieved by adopting respiratory therapy is better.

In conclusion, the medicament for treating the respiratory diseases has a killing effect on various pneumonia and tuberculosis viruses, has a good treatment effect on respiratory diseases, digestive diseases and blood diseases, is not easy to relapse, and has no toxic or side effect.

According to the preparation method of the medicine for treating the respiratory diseases, disclosed by the embodiment of the invention, the raw materials are treated by adopting a distillation process, so that the active ingredients of the raw materials are better extracted, the content of the active ingredients can be increased, and the concentration of the active ingredients in the liquid medicine is higher, so that the medicine can better exert the medicine effect, and the treatment effect of the medicine on the respiratory diseases is enhanced.

The embodiments described above are some, but not all embodiments of the invention. The detailed description of the embodiments of the present invention is not intended to limit the scope of the invention as claimed, but is merely representative of selected embodiments of the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.

Claims

1. The medicine for treating the respiratory diseases is characterized by comprising the following raw materials in parts by mass: 5-15% of astragalus membranaceus, 6-18% of pneumocardial, 10-20% of honeysuckle, 5-12% of ginseng, 3-14% of apricot kernel and 40-60% of fruit stone.

2. The medicament of claim 1, wherein the kernels comprise raw tea fruits, melons and fruits and branchlet fruits.

3. The medicament of claim 2, wherein the raw tea fruits comprise camellia oleifera fruits, white tea fruits, camellia fruits and ampelopsis grossedentata fruits.

4. The medicament of claim 2, wherein the melon and fruit includes pear, cherry, sugarcane, lemon, loquat, apple, and orange.

5. A process for the preparation of a medicament as claimed in any one of claims 1 to 4, comprising the steps of: mixing radix astragali, cor pulmonale, flos Lonicerae, Ginseng radix, semen Armeniacae amarum and semen Persicae to obtain a mixture, adding water into the mixture, vacuum distilling, and filtering to obtain medicinal liquid.

6. The method of claim 5, further comprising soaking the mixture in 80-90 wt% ethanol for 20-30min before vacuum distillation.

7. The method as claimed in claim 5, further comprising pulverizing the mixture to a fine powder having a particle size of 150-200 mesh prior to the vacuum distillation.

8. The method as claimed in claim 5, wherein the distillation is carried out at 120 ℃ for 40-50 min.

9. The method as claimed in claim 5, further comprising centrifugation at 1000r/min at 800-.

10. The method of claim 5, further comprising concentrating the liquid medicine, drying, and making into capsule.